HMC starts COVID-19 patients' treatment with convalescent plasma

HMC starts COVID-19 patients' treatment with convalescent plasma

HMC starts COVID-19 patients' treatment with convalescent plasma

"It's possible that ... the antibodies in that plasma from the patient who recovered, would then be there to attack the virus in the patient who is still ill", Devine said in a video statement.

Recovered COVID-19 patient Paul Butler donates plasma Monday, April 27, 2020, at LifeShare Blood Center in Texarkana, Texas.

People who have recovered from COVID-19 may be able to donate their plasma to help in the fight against the novel coronavirus.

Straus hopes other recovered patients will reach out to the Community Blood Center to donate plasma. Plasma-derived therapeutics have also been successfully used to treat diseases such as tetanus, hepatitis B and rabies for many years.

If you want to become a convalescent plasma donor, you can apply at or call 6866-CVPLSMA (866-287-5752).

"We're clearing our shelves of them every day", Prijatel said. COVID-19 has proved to be far more risky than SARS but both are categorised as a coronavirus, so scientists hope that the treatment will have a similar effect on this latest outbreak.

Before making her convalescent plasma donation, Kahn had to qualify for this no-cost procedure, which only collects plasma from your blood and returns donor's red blood cells to their system.

LifeShare is unable to test COVID-19 convalescent plasma to determine the amount of antibodies it contains, but that testing is taking place at hospitals where the plasma is used.

During the SARS (severe acute respiratory syndrome) outbreak of 2003 scientists found that convalescent plasma was an effective treatment for sufferers.

London's Guy's and St Thomas' Hospital, which Prime Minister Boris Johnson said helped save his life after he fell gravely ill with COVID-19, is to test the so-called "convalescent plasma" treatment as part of an global trial. It is derived from patients who have already contracted the virus, developed antibodies against it and are no longer infected.

The BBC reported there was now enough plasma to transfuse to 143 patients. But for the past two weeks, LifeShare has taken in less blood than it has distributed, and he is concerned that the blood supply may be strained in May.

Related news

[an error occurred while processing the directive]